ZA962060B - Topical ophthalmic composition comprising a 2-(4-(azolylbutyl)-piperazinyl)benzimidazole derivative in particular for the treatment of allergic conjunctivitis - Google Patents

Topical ophthalmic composition comprising a 2-(4-(azolylbutyl)-piperazinyl)benzimidazole derivative in particular for the treatment of allergic conjunctivitis

Info

Publication number
ZA962060B
ZA962060B ZA962060A ZA962060A ZA962060B ZA 962060 B ZA962060 B ZA 962060B ZA 962060 A ZA962060 A ZA 962060A ZA 962060 A ZA962060 A ZA 962060A ZA 962060 B ZA962060 B ZA 962060B
Authority
ZA
South Africa
Prior art keywords
azolylbutyl
piperazinyl
treatment
ophthalmic composition
allergic conjunctivitis
Prior art date
Application number
ZA962060A
Other languages
English (en)
Inventor
Maria Rosa Cuberes-Altisent
Jordi Frigola-Constansa
Original Assignee
Esteve S A Lab Des Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve S A Lab Des Dr filed Critical Esteve S A Lab Des Dr
Publication of ZA962060B publication Critical patent/ZA962060B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA962060A 1995-03-14 1996-03-14 Topical ophthalmic composition comprising a 2-(4-(azolylbutyl)-piperazinyl)benzimidazole derivative in particular for the treatment of allergic conjunctivitis ZA962060B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9502910A FR2731618B1 (fr) 1995-03-14 1995-03-14 Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique

Publications (1)

Publication Number Publication Date
ZA962060B true ZA962060B (en) 1996-12-31

Family

ID=9476989

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA962060A ZA962060B (en) 1995-03-14 1996-03-14 Topical ophthalmic composition comprising a 2-(4-(azolylbutyl)-piperazinyl)benzimidazole derivative in particular for the treatment of allergic conjunctivitis

Country Status (9)

Country Link
US (1) US5641781A (de)
EP (1) EP0760663A1 (de)
JP (1) JPH10500427A (de)
AU (1) AU718008B2 (de)
CA (1) CA2190187A1 (de)
ES (1) ES2117558B1 (de)
FR (1) FR2731618B1 (de)
WO (1) WO1996028161A1 (de)
ZA (1) ZA962060B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
JP2006505585A (ja) * 2002-10-18 2006-02-16 モリケム メディシンズ， インコーポレイテッド ランチビオティクスで眼乾燥症を処置する方法
WO2005107787A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
EP1753445A4 (de) * 2004-05-06 2009-05-20 Molichem Medicines Inc Behandlung von augenerkrankungen und augenleiden mit lantibiotischen zusammensetzungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
JP3527256B2 (ja) * 1992-12-09 2004-05-17 ロート製薬株式会社 抗アレルギー点眼剤

Also Published As

Publication number Publication date
FR2731618B1 (fr) 1997-08-01
US5641781A (en) 1997-06-24
EP0760663A1 (de) 1997-03-12
AU718008B2 (en) 2000-04-06
WO1996028161A1 (fr) 1996-09-19
CA2190187A1 (fr) 1996-09-19
ES2117558B1 (es) 1999-09-16
ES2117558A1 (es) 1998-08-01
AU5145296A (en) 1996-10-02
JPH10500427A (ja) 1998-01-13
FR2731618A1 (fr) 1996-09-20

Similar Documents

Publication Publication Date Title
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
LTC0914118I2 (lt) Pakeistieji 3,5-difenil-1,2,4-triazolai ir jų panaudojimas farmaciniais metalų chelatoriais
FI943164L (fi) 2-(1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli)tiokarbapeneemijohdannaisia
NO20014617L (no) 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer
DE69613377D1 (de) 2-(4-substituierte)-benzylamino-2-methyl-propanamid-derivate
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
AU6932000A (en) Tacrine derivatives for treating alzheimer's disease
NO973508L (no) Antipsykotiske 4-(1H-indol-l-yl)-piperidinylderivater
NZ307958A (en) Benzisoxazole and indazole derivatives as long acting antipsychotic agents and particularly in the treatment of schizophrenia
IL125002A0 (en) Novel substituted 4-(1H-benzimidazol-2-yl) [1,4] diazepanes useful for the treatment of allergic diseases
ZA962060B (en) Topical ophthalmic composition comprising a 2-(4-(azolylbutyl)-piperazinyl)benzimidazole derivative in particular for the treatment of allergic conjunctivitis
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
MX9205186A (es) Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona
AU5533300A (en) Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia
FI964019L (fi) Kinolonijohdannainen virtsainkontinenssin hoitoon
NO983829L (no) Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer
AU2002213878A1 (en) Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychoses
AU8626398A (en) Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis
EE9400039A (et) Oftalmiliseks otstarbeks mõeldud kompositsioon
ZA969484B (en) Novel substituted 4-(1H-benzimidazol-2-yl-amino)- piperidines useful for the treatment of allergic diseases
AU1862395A (en) Novel 2-(imidazolylmethyl)thiazole derivative and medicinal comp osition thereof
SI0874843T1 (en) Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases
DZ3481A1 (fr) Derive de thiazolidinedione et son utilisation en tant qu'agent anti-diabetique
KR960020309U (ko) 압연롤의 쵸크 분해 조립용 베드
ITPD940004V0 (it) "cerniera perfezionata per occhiali"